Celvive, Inc. is dedicated to refining a technology for the isolation and use of autologous stem cells for regenerative medicine applications with an initial focus on neural regeneration in patients of spinal cord injury (SCI). The company has developed a new approach, using a closed bag system to isolate specific Adult Stem Cells from the patients' self Bone Marrow to treat SCI.

Industry Categories

Industry Biomedical
Sub-industry
Focus Areas
Focus Areas - detailed

University

University Rutgers
Principal Investigator Hatem Sabaawy, M.D., Ph.D. - Cancer Institute of New Jersey, Rutgers Biomedical and Health Sciences

Company

Web http://celvive.com
Address New Brunswick, NJ
Phone
Email

Timeline

  • 2011 – Founded


No files attached to this page.

Add a New Comment